The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 27, 2021

Filed:

Aug. 18, 2015
Applicant:

Helmholtz-zentrum Fuer Infektionsforschung Gmbh, Braunschweig, DE;

Inventors:

Mark Broenstrup, Braunschweig, DE;

Haiyu Hu, Wolfenbuettel, DE;

Galina Sergeev, Wolfsburg, DE;

Bushra Rais, Lucknow, IN;

Kevin Ferreira, Braunschweig, DE;

Verena Fetz, Braunschweig, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 257/02 (2006.01); C07D 403/14 (2006.01); C07D 491/16 (2006.01); A61K 49/00 (2006.01); C07H 17/04 (2006.01); C12Q 1/16 (2006.01);
U.S. Cl.
CPC ...
C07D 257/02 (2013.01); A61K 49/0023 (2013.01); A61K 49/0032 (2013.01); A61K 49/0052 (2013.01); C07D 403/14 (2013.01); C07D 491/16 (2013.01); C07H 17/04 (2013.01); C12Q 1/16 (2013.01); G01N 2800/26 (2013.01);
Abstract

The present invention relates to new compounds comprising a siderophore moiety as well as a core structure able to chelate a metal ion. Optionally, the compounds may have additionally a moiety with a functional element including a marker molecule, a bioactive agent, an activity based probe suitable to monitor the aberrant expression or activity of proteins involved in the initiation and progression of bacterial infection, or a compound useful for bacterial inhibition. In a further aspect, the present invention provides a pharmaceutical composition containing said compound, for example, said pharmaceutical composition is an antibiotic. Additionally, the present invention relates to the use of said compounds in diagnostic methods, in particular, imaging methods including SPEC, PET or MRI. In an embodiment of the present invention, the compound is part of a theranostic composition having both, therapeutic as well as diagnostic activities.


Find Patent Forward Citations

Loading…